Electronic prescribing of controlled substances (EPCS) delivers a number of benefits.
It helps address prescription drug abuse by reducing “doctor shopping” and minimizing the risk of altered, stolen, or fraudulent prescriptions.
It also helps to eliminate dual workflows and improve patient safety.
To realize these benefits, healthcare organizations must implement EPCS systems that meet DEA requirements, which can present a challenge to implementation and physician adoption.
Cambridge Health Alliance (CHA) – one of Massachusetts’ largest academic healthcare systems – has successfully deployed Imprivata Confirm ID™, a comprehensive platform that meets the DEA authentication requirements for EPCS. The solution includes Imprivata’s breakthrough, proximity-based Hands Free Authentication, which gives providers a fast, secure, and efficient option for two-factor authentication.
Listen to this on-demand webinar, to hear CHA’s Arthur Ream III, Director of IT Applications and CISO, discuss the strategies CHA used to successfully integrate Imprivata Confirm ID with Epic, to meet DEA requirements for EPCS while driving physician adoption.
In this webinar you’ll learn:
- CHA’s drivers for implementing EPCS, the challenges it faced, and results
- How to eliminate dual prescribing workflows and improve provider satisfaction with Hands Free Authentication
- Best practices for a successful EPCS integration with Epic in your own organization